Pfizer Inc.
PFE
$23.97
$0.100.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.84B | 7.88B | 8.03B | 4.25B | -2.60B |
| Total Depreciation and Amortization | 5.15B | 6.88B | 6.99B | 6.87B | 6.68B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 893.00M | 879.00M | 785.00M | -2.32B | 3.54B |
| Change in Net Operating Assets | 1.89B | -1.65B | -3.07B | 2.46B | 380.00M |
| Cash from Operations | 15.77B | 13.99B | 12.74B | 11.26B | 8.01B |
| Capital Expenditure | -2.13B | -2.77B | -2.91B | -3.04B | -3.20B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -43.41B | -43.41B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.73B | 6.96B | 5.56B | 39.72B | 42.82B |
| Cash from Investing | -406.00M | 4.19B | 2.65B | -6.72B | -3.78B |
| Total Debt Issued | 2.89B | 7.46B | 8.91B | 15.85B | 13.66B |
| Total Debt Repaid | -10.30B | -14.88B | -16.07B | -12.51B | -9.51B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.20B | -9.58B | -9.51B | -9.45B | -9.38B |
| Other Financing Activities | -376.00M | -439.00M | -469.00M | -473.00M | -504.00M |
| Cash from Financing | -14.98B | -17.44B | -17.14B | -6.58B | -5.73B |
| Foreign Exchange rate Adjustments | -27.00M | -45.00M | -66.00M | -38.00M | -79.00M |
| Miscellaneous Cash Flow Adjustments | -2.00M | -1.00M | 0.00 | 0.00 | 3.00M |
| Net Change in Cash | 358.00M | 701.00M | -1.81B | -2.08B | -1.57B |